Showing results (1131-1140 of 1,412) with videos related to
Sort By:
Pageof 142
NPJ Parkinson'S Disease|October 25, 2024
CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variantsStefanie Lerche, Isabel Wurster, Enza Maria Valente, et al.NPJ Parkinson'S Disease|October 27, 2024
Microbial biomarker discovery in Parkinson's disease through a network-based approachZhe Zhao, Jing Chen, Danhua Zhao, et al.NPJ Parkinson'S Disease|February 28, 2025
Novel co-culture model of T cells and midbrain organoids for investigating neurodegeneration in Parkinson's diseaseElizaveta Gerasimova, Amke C Beenen, Daniil Kachkin, et al.NPJ Parkinson'S Disease|March 4, 2025
A personalised and comprehensive approach is required to suppress or replenish SNCA for Parkinson's diseaseDunhui Li, Wai Yan Yau, Shengdi Chen, et al.NPJ Parkinson'S Disease|February 19, 2025
Prasinezumab slows motor progression in Parkinsons disease: beyond the clinical dataBin Xiao, Eng-King TanNPJ Parkinson'S Disease|February 14, 2025
Patient-centered brain transcriptomic and multimodal imaging determinants of clinical progression, physical activity, and treatment needs in Parkinson's diseaseQuadri Adewale, Ahmed Faraz Khan, Sue-Jin Lin, et al.NPJ Parkinson'S Disease|August 7, 2024
The digital signature of emergent tremor in Parkinson's diseaseAryaman S Gala, Kevin B Wilkins, Matthew N Petrucci, et al.NPJ Parkinson'S Disease|July 29, 2024
Molecular properties and diagnostic potential of monoclonal antibodies targeting cytotoxic α-synuclein oligomersJanni Nielsen, Johanne Lauritsen, Jannik N Pedersen, et al.NPJ Parkinson'S Disease|July 28, 2024
Human tripartite cortical network model for temporal assessment of alpha-synuclein aggregation and propagation in Parkinson's DiseaseFikret Emre Kapucu, Iisa Tujula, Oskari Kulta, et al.NPJ Parkinson'S Disease|August 2, 2024
GBA-AAV mitigates sleep disruptions and motor deficits in mice with REM sleep behavior disorderYing Chen, Wei-Ye Xie, Dong Xia, et al.Pageof 142